Table 2.
Baseline prevalence (percent) and 95% confidence interval (CI) of individual geriatric syndromes (GS) by GS total for women aged 65 years and older from the Women’s Health Initiative Observational Study at baseline.
| Total Prevalence (n=29544) | 1 GS (n=8586) | 2 GS (n=6635) | 3 GS (n=3718) | 4 GS (n=1780) | 5+ GS (n=1040) | |
|---|---|---|---|---|---|---|
|
| ||||||
| Prevalence (95% CI) | Prevalence (95% CI) | Prevalence (95% CI) | Prevalence (95% CI) | Prevalence (95% CI) | Prevalence (95% CI) | |
| Depressive symptoms | 8.0 (7.7, 8.3) | 3.4 (3.0, 3.8) | 8.2 (7.5, 8.9) | 14.4 (13.3, 15.6) | 24.5 (22.5, 26.5) | 44.5 (41.5, 47.5) |
| Dizziness | 18.6 (18.1, 19.0) | 9.0 (8.4, 9.6) | 21.3 (20.3, 22.3) | 36.8 (35.2, 38.3) | 53.1 (50.8, 55.4) | 74.5 (71.9, 77.2) |
| Falls | 11.3 (10.9, 11.6) | 5.8 (5.3, 6.3) | 13.2 (12.4, 14.0) | 21.4 (20.1, 22.7) | 30.7 (28.6, 32.9) | 46.7 (43.7, 49.8) |
| Hearing Impairment | 29.2 (28.6, 29.7) | 21.9 (21.0, 22.8) | 38.6 (37.4, 39.8) | 53.0 (51.4, 54.6) | 64.1 (61.9, 66.3) | 73.4 (70.7, 76.1) |
| Osteoporosis | 11.8 (11.4, 12.1) | 7.5 (6.9, 8.0) | 14.1 (13.3, 15.0) | 21.7 (20.4, 23.0) | 29.3 (27.2, 31.4) | 39.9 (36.9, 42.9) |
| Polypharmacy | 22.0 (21.6, 22.5) | 14.1 (13.4, 14.8) | 28.6 (27.5, 29.7) | 41.3 (39.8, 42.9) | 53.0 (50.7, 55.4) | 68.2 (65.3, 71.0) |
| Sleep Disturbance | 7.7 (7.4, 8.0) | 4.3 (3.9, 4.7) | 9.2 (8.5, 9.9) | 14.4 (13.3, 15.6) | 19.3 (17.4, 21.1) | 31.0 (28.2, 33.8) |
| Syncope | 2.4 (2.2, 2.6) | 1.0 (0.8, 1.2) | 2.4 (2.1, 2.8) | 4.3 (3.7, 5.0) | 7.8 (6.5, 9.0) | 13.7 (11.6, 15.7) |
| Urinary Incontinence | 29.3 (28.8, 29.9) | 22.3 (21.5, 23.2) | 39.3 (38.1, 40.4) | 52.9 (51.3, 54.5) | 62.6 (60.4, 64.9) | 73.8 (71.1, 76.4) |
| Visual Impairment | 20.5 (20.0, 20.9) | 10.7 (10.1, 11.4) | 25.1 (24.1, 26.1) | 39.7 (38.2, 41.3) | 55.6 (53.3, 57.9) | 74.3 (71.7, 77.0) |